{"adverse_reactions":["Sincerus Florida, LLC. Adverse reactions s"],"components":["Active, inactive ff"],"effective_time":"20190515","id":"88f00580-a0ca-168f-e053-2a95a90a6e4b","instructions_for_use":["Directions for use zx"],"openfda":{},"package_label_principal_display_panel":["NDC 72934- 1028-2 BRIMONIDINE TARTRATE USP 0.25% / IVERMECTIN USP 1% / METRONIDAZOLE USP 1% / NIACINAMIDE USP 4% c"],"set_id":"88f00580-a0c9-168f-e053-2a95a90a6e4b","spl_product_data_elements":["BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4% BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4% BRIMONIDINE TARTRATE BRIMONIDINE METRONIDAZOLE METRONIDAZOLE NIACINAMIDE NIACINAMIDE IVERMECTIN IVERMECTIN OFF WHITE GEL"],"version":"1"}